Grapevine: PE-backed Sekhmet in fray for Glenmark's arm; Easebuzz to raise fresh funding

Gamot API-operated active pharma ingredient platform Sekhmet Pharmaventures is in the fray with Ahmedabad-based Nirma Group for acquisition of Glenmark Pharma’s subsidiary, said a media report, citing several people aware of the development.   Sekhmet, backed by the likes of PAG, CX Partners and Samara Capital is also likely to have ......